-- Days : -- HRS : -- MIN : -- SEC
Register Now →

Population Health

Latest Content


In this segment of the panel discussion, Dr Fendrick asks the panelists if there is now a sense of optimism in reducing the mortality and quality gaps in prostate cancer treatment due to targeted screening and new molecular diagnostics, and immunotherapies.